Share Twitter Facebook LinkedIn Email Moderna’s announcement comes as COVID-19 cases due to Omicron subvariants are on the rise, but vaccination and booster rates are not increasing as needed. Read More
US aims for ‘economic asphyxiation’ of Iranian regime with new wave of secondary sanctionsAugust 24, 2026